Switch to optionsXpress for advanced derivatives trading & earn 50 commission-free trades.
Advertisement
SureTrader Stock Hero Advertisement
Home > Boards > US Listed > Biotechs >

Organovo Holdings, Inc. (ONVO)

ONVO RSS Feed
Add ONVO Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator dshade, grantg2, Big_Money_Upward
Search This Board:
Last Post: 3/31/2015 11:19:43 AM - Followers: 291 - Board type: Free - Posts Today: 2
WELCOME TO THE ORGANOVO BOARD


 
     Organovo is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications.
The company's NovoGen three-dimensional bioprinting technology is a platform that works across all tissue and cell types.
Organovo's NovoGen MMX Bioprinter was selected as one of the "Best Inventions of 2010" by TIME Magazine.
Organovo is helping pharmaceutical partners develop human biological disease models in three dimensions that enable therapeutic drug discovery and development.
Organovo's bioprinting technology can also be developed to create surgical tissues direct therapy.
Organovo leads the way in solving complex medical research problems and building the future of medicine.

COMPANY PROFILE via YouTube
http://www.youtube.com/watch?feature=player_embedded&v=-A-uH15bQZw

 
ONVO Security Details Share Structure

Shares Outstanding 77,816,787 a/o Mar 16, 2014
Float 50,000,000 a/0 May24,2014
Authorized Shares 150,000,000 a/o May24, 2014


IR and Media Contacts:
Investor Relations Contact: ir@organovo.com
Media Contact: media@organovo.com

Mailing Address:
Organovo, Inc.
6275 Nancy Ridge Drive, Suite 110
San Diego, CA 92121
Phone: 1-858-550-9994


For all the latest company information, details, news, please visit http://www.organovo.com

 
Organovo's Scientific Founder and Chief Scientific Officer, Dr. Gabor Forgacs
is the Executive and Scientific Director of the Shipley Center for Innovation at Clarkson University and the George H. Vineyard Professor of Biological Physics at the University of Missouri.
He developed Organovo's breakthrough organ printing technology while leading a team of top regenerative medicine scientists from multiple universities, with the backing of a $5MM National Science Foundation Grant.
Professor Forgacs is the author of more than 150 peer reviewed journal articles and the textbook Biological Physics of the Developing Embryo, (with Stuart Newman), published by Cambridge University Press.
He holds a PhD in theoretical physics from the Roland Eotvos University, Budapest Hungary. He moved to the United States in the 1980's from the Institute of Physics of the French Atomic Energy Agency in Saclay to accept a professorship at Clarkson University. 
University of Missouri researcher doing groundbreaking work in regenerative medicine. Here is a video:

Science

Organovo strives to advance regenerative medicine to new heights, by enabling bioprinting tissues and 3-D cellular constructs that were not possible before.
The novel and flexible capabilities of the bioprinting technology allow researchers to generate data faster and more efficiently, thus leading to cutting edge scientific findings, publications, and grants.

Organovo's 3-D NovoGen bioprinting technology allows for the placement of cells in any pattern desired.
First, small building blocks of any shape are created from the desired cell type.
Second, these pre-formed cell aggregates are loaded into a print cartridge that is then attached to the bio-printer.
The bioprinter deposits the cell aggregates one layer at a time, creating multiple stacked 2-D patterns.
A non-invasive gel is placed next to the cell aggregates to hold the desired 3-D shape as each layer is placed in 2-D.

After printing, the cell aggregates retain enough cellular mobility for them to flow into one another, creating a fused tissue construct.
The principles of developmental biology, including cellular self-assembly, allow the final construct to mature into the desired shape and properties.

 

World class support for NovoGen MMX

The NovoGen MMX Bioprinter™ is supported by our scientific and engineering team.
Every customer receives bioprinter training and access to Organovo's scaffold-free proprietary bioprinting process, which includes cell preparation to tissue maturation.
Additional consultation and application support are available upon request. Organovo's success comes from enabling our customers' success.  

 

NovoGen MMX Bioprinter

    The NovoGen MMX Bioprinter™ is a novel hardware and software platform at the forefront of bioprinting research and development. The NovoGen MMX™ was developed to meet challenges in biological research.
The platform takes primary or other human cells and shapes them into 3D tissue, with tremendous cellular viability and biology that is superior to even an animal model.
The platform is being used by Organovo's Pharma partners today to enable cutting edge research into drug discovery.

By allowing creation of three dimensional biological structures, Organovo creates functional human tissue that is superior to current disease models.
By enabling printing of tissue in a laboratory environment, investigations on the constructs can be integrated into your current analysis methods.

http://www.invetech.com.au/portfolio/life-sciences/3d-bioprinter-world-first-print-human-tissue/
http://techli.com/2012/07/organovo-bioprinting/#.
https://www.youtube.com/watch?v=1O3c3pUg0L8 (at 28 sec into the video is a full frontal view of the ONVO NovaGen MMX Bioprinter)

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ONVO
Current Price
Volume:
Bid Ask Day's Range
Wiki
ONVO News: Amended Current Report Filing (8-k/a) 03/19/2015 05:02:34 PM
ONVO News: Notice of Effectiveness (effect) 03/18/2015 06:01:41 AM
ONVO News: Current Report Filing (8-k) 03/13/2015 05:09:20 PM
ONVO News: Organovo Provides Market Update 03/13/2015 08:05:00 AM
ONVO News: Is There Still Room For Shorting Organovo? 03/12/2015 03:49:36 AM
PostSubject
#7214  Sticky Note Article today on CNN money shorty355 11/04/14 10:44:51 AM
#6278  Sticky Note ONVO news: "Organovo Reports Positive Results from a rayank 06/26/14 10:25:47 AM
#6071  Sticky Note ONVO Kidney news & Profile videos dshade 05/24/14 12:15:04 PM
#8026   The Captain's at_the_door_with_an_Axe_As_we_descend_towards_APRIL rumper 03/31/15 11:19:43 AM
#8025   $ONVO OVERSOLD I am in and strong position..Very Mr3Deeprint 03/31/15 04:32:37 AM
#8024   I'd Say We're Getting Oversold rumper 03/30/15 01:27:16 PM
#8023   This will get taken down to under 3 doglover1 03/30/15 01:18:39 PM
#8022   I may enter ONVO today (for short term HHHG 03/30/15 12:47:03 PM
#8021   Amazing Video of The Future Potential For ONVO rumper 03/29/15 05:52:06 PM
#8020   I am also watching this ONVO (latest quote HHHG 03/28/15 10:27:35 PM
#8019   Under $10 on a $3 stock LOL rumper 03/28/15 07:11:01 AM
#8018   Never wrong buying ONVO under $10 IMHO. RandolRocketman 03/28/15 12:55:41 AM
#8017   When is next quarter? Lot37 03/27/15 12:50:43 PM
#8016   Join the "wrong" club. LOL I have been rayank 03/27/15 12:29:50 PM
#8015   That didn't take long to be Wrong rumper 03/27/15 12:27:39 PM
#8014   Agree we keep hitting new lows, so no rayank 03/27/15 12:27:19 PM
#8013   Not sure what "bottom" you were referring to, Alvie 03/27/15 12:21:15 PM
#8012   At the bottom, and profits coming soon? I rayank 03/27/15 12:18:01 PM
#8011   When ThisThing Rallys, it's_Gonna_Be_a_HeartPounder! rumper 03/27/15 10:56:29 AM
#8010   Then I fail to see the anger directed RallyTheMarket 03/26/15 03:23:50 PM
#8009   Only an idiot bought $12. All free shares dshade 03/26/15 03:06:01 PM
#8008   Laughing at it taking 2.5 years to destroy RallyTheMarket 03/26/15 03:01:53 PM
#8007   Yeah it's been a barrel of laughs. It's RallyTheMarket 03/26/15 02:54:41 PM
#8006   Correct. 2.5 years later you finally got the dshade 03/26/15 02:48:19 PM
#8005   I don't think I ever said I was rayank 03/26/15 02:37:52 PM
#8004   Oh ok, then Andre Waldron, Market Eyewitness rayank 03/26/15 02:35:14 PM
#8003   The Shorts are Slapping ONVO like_a_Little_Beeoch rumper 03/26/15 02:21:10 PM
#8002   Looks like longs are beginning to reevaluate their RallyTheMarket 03/26/15 01:16:46 PM
#8001   Because sooo many people frequent this website? Hah adeezl 03/26/15 01:13:35 PM
#8000   Weren't you a hater for months as well? adeezl 03/26/15 01:12:30 PM
#7999   I don't care, nor believe it. What is adeezl 03/26/15 01:11:34 PM
#7998   Incorrect - $4-5 stock.. right now sub $4 stock. adeezl 03/26/15 01:10:13 PM
#7997   I already replied to that one; I was Alvie 03/26/15 01:03:54 PM
#7996   Hey Gandhi: "short this"! rayank 03/26/15 12:50:52 PM
#7995   Send that SA "clown" a message. (link back) rayank 03/26/15 12:49:30 PM
#7994   His name is Akshansh Gandhi and you can rayank 03/26/15 12:48:27 PM
#7993   Who is the clown that wrote the latest Alvie 03/26/15 12:29:08 PM
#7992   Yes unfortunately. rayank 03/26/15 11:28:16 AM
#7991   Expected more pressure after short article paid for dshade 03/26/15 11:27:07 AM
#7990   Yes I hear you dshade, but the price rayank 03/26/15 11:25:58 AM
#7989   My horizon is long and regardless of short dshade 03/26/15 11:24:37 AM
#7988   WOW $3.85 and falling - When I started rayank 03/26/15 11:20:33 AM
#7987   Re ONVO dshade 03/25/15 08:16:45 PM
#7986   420 Cbdpotential 03/23/15 03:43:36 PM
#7985   :-) rayank 03/23/15 02:36:21 PM
#7984   Great post Thank you Cbdpotential 03/23/15 12:51:24 PM
#7983   Gee, Ya Think ! rumper 03/23/15 10:01:53 AM
#7982   ONVO article just out: “We may not rayank 03/23/15 06:35:31 AM
#7981   I see. Thanks for the reply. Mjmillions 03/22/15 10:47:59 PM
#7980   Correct, bought on 8/23/12 at $2.19, sold half Alvie 03/22/15 10:46:49 PM
#7979   You bought in 2012? And you're posting now Mjmillions 03/22/15 08:07:53 PM
#7978   I totally agree. Oversold. Mjmillions 03/22/15 08:03:13 PM
#7977   Excellent sentiment! I'd be happy to get $6 Mjmillions 03/22/15 08:01:58 PM
PostSubject